Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example

被引:57
作者
de Jong, Valentijn M. T. [1 ]
Moons, Karel G. M. [1 ,2 ]
Riley, Richard D. [3 ]
Tudur Smith, Catrin [4 ]
Marson, Anthony G. [5 ]
Eijkemans, Marinus J. C. [1 ]
Debray, Thomas P. A. [1 ,2 ]
机构
[1] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Cochrane Netherlands, Utrecht, Netherlands
[3] Keele Univ, Ctr Prognosis Res, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England
[4] Univ Liverpool, Dept Biostat, Liverpool, Merseyside, England
[5] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool, Merseyside, England
基金
欧盟地平线“2020”;
关键词
heterogeneity; individual participant data; intervention; meta-analysis; time-to-event; PROPORTIONAL HAZARDS MODEL; SURROGATE END-POINTS; PATIENT DATA METAANALYSIS; HETEROGENEITY VARIANCE ESTIMATORS; TREATMENT-COVARIATE INTERACTIONS; CONDITIONAL AKAIKE INFORMATION; MEAN SURVIVAL-TIME; REGRESSION-MODELS; CLINICAL-TRIALS; COMPETING RISKS;
D O I
10.1002/jrsm.1384
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many randomized trials evaluate an intervention effect on time-to-event outcomes. Individual participant data (IPD) from such trials can be obtained and combined in a so-called IPD meta-analysis (IPD-MA), to summarize the overall intervention effect. We performed a narrative literature review to provide an overview of methods for conducting an IPD-MA of randomized intervention studies with a time-to-event outcome. We focused on identifying good methodological practice for modeling frailty of trial participants across trials, modeling heterogeneity of intervention effects, choosing appropriate association measures, dealing with (trial differences in) censoring and follow-up times, and addressing time-varying intervention effects and effect modification (interactions).We discuss how to achieve this using parametric and semi-parametric methods, and describe how to implement these in a one-stage or two-stage IPD-MA framework. We recommend exploring heterogeneity of the effect(s) through interaction and non-linear effects. Random effects should be applied to account for residual heterogeneity of the intervention effect. We provide further recommendations, many of which specific to IPD-MA of time-to-event data from randomized trials examining an intervention effect.We illustrate several key methods in a real IPD-MA, where IPD of 1225 participants from 5 randomized clinical trials were combined to compare the effects of Carbamazepine and Valproate on the incidence of epileptic seizures.
引用
收藏
页码:148 / 168
页数:21
相关论文
共 185 条
[1]  
Aalen O O, 1994, Stat Methods Med Res, V3, P227, DOI 10.1177/096228029400300303
[2]   Does Cox analysis of a randomized survival study yield a causal treatment effect? [J].
Aalen, Odd O. ;
Cook, Richard J. ;
Roysland, Kjetil .
LIFETIME DATA ANALYSIS, 2015, 21 (04) :579-593
[3]   The unobserved heterogeneity distribution in duration analysis [J].
Abbring, Jaap H. ;
Van den Berg, Gerard J. .
BIOMETRIKA, 2007, 94 (01) :87-99
[4]   Individual participant data meta-analyses should not ignore clustering [J].
Abo-Zaid, Ghada ;
Guo, Boliang ;
Deeks, Jonathan J. ;
Debray, Thomas P. A. ;
Steyerberg, Ewout W. ;
Moons, Karel G. M. ;
Riley, Richard David .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2013, 66 (08) :865-873
[5]   Competing risks in epidemiology: possibilities and pitfalls [J].
Andersen, Per Kragh ;
Geskus, Ronald B. ;
de Witte, Theo ;
Putter, Hein .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (03) :861-870
[6]   Measures of single arm outcome in meta-analyses of rare events in the presence of competing risks [J].
Andreano, Anita ;
Rebora, Paola ;
Valsecchi, Maria Grazia .
BIOMETRICAL JOURNAL, 2015, 57 (04) :649-660
[7]  
[Anonymous], 2000, Analysis of multivariate survival data
[8]  
[Anonymous], 2011, Frailty Models in Survival Analysis
[9]  
Audigier V., 2017, micemd: Multiple imputation by chained equations with multilevel data
[10]   The median hazard ratio: a useful measure of variance and general contextual effects in multilevel survival analysis [J].
Austin, Peter C. ;
Wagner, Philippe ;
Merlo, Juan .
STATISTICS IN MEDICINE, 2017, 36 (06) :928-938